Antioxidants prevent oxidative DNA damage and cellular transformation elicited by the over-expression of c-MYC

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 593, Issue 1-2, 2006, Pages 64-79

  Kc, Sagun ^a,b   Cárcamo, Juan M ^b   Golde, David W ^a,b  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

8 Oxo dG; Foci; Mitochondria; ROS; Superoxide; Vitamin C

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; REACTIVE OXYGEN METABOLITE; TIRON;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CELL TRANSFORMATION; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE C MYC; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; GENE EXPRESSION REGULATION; GENES, MYC; GLUTATHIONE; HUMANS; MICE; OXIDATIVE STRESS; RATS; SUPEROXIDES;

ANIMALIA;

EID: 30944440458     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2005.06.015     Document Type: Article

References (61)

1. P. Cerutti, G. Shah, A. Peskin, and P. Amstad Oxidant carcinogenesis and antioxidant defense Ann. N.Y. Acad. Sci. 663 1992 158 166
2. P.A. Cerutti Prooxidant states and tumor promotion Science 227 1985 375 381
3. B. Halliwell, and J.M.C. Gutteridge Free Radicals in Biology and Medicine 1989 Clarendon Press Oxford
4. C.V. Dang c-Myc target genes involved in cell growth, apoptosis, and metabolism Mol. Cell. Biol. 19 1999 1 11
5. S. Pelengaris, M. Khan, and G. Evan c-MYC: more than just a matter of life and death Nat. Rev. Cancer 2 2002 764 776
6. K.B. Marcu, S.A. Bossone, and A.J. Patel myc function and regulation Annu. Rev. Biochem. 61 1992 809 860
7. D.W. Felsher, and J.M. Bishop Transient excess of MYC activity can elicit genomic instability and tumorigenesis Proc. Natl. Acad. Sci. U.S.A. 96 1999 3940 3944
8. O. Vafa, M. Wade, S. Kern, M. Beeche, T.K. Pandita, G.M. Hampton, and G.M. Wahl c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability Mol. Cell 9 2002 1031 1044
9. H. Tanaka, I. Matsumura, S. Ezoe, Y. Satoh, T. Sakamaki, C. Albanese, T. Machii, R.G. Pestell, and Y. Kanakura E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination Mol. Cell 9 2002 1017 1029
10. G.M. Ramsay, G. Moscovici, C. Moscovici, and J.M. Bishop Neoplastic transformation and tumorigenesis by the human protooncogene MYC Proc. Natl. Acad. Sci. U.S.A. 87 1990 2102 2106
11. B. Mukherjee, S.D. Morgenbesser, and R.A. DePinho Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants Genes Dev. 6 1992 1480 1492
12. S. Katzav, G. Packham, M. Sutherland, P. Aroca, E. Santos, and J.L. Cleveland Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function Oncogene 11 1995 1079 1088
13. K. Haas, C. Johannes, C. Geisen, T. Schmidt, H. Karsunky, S. Blass-Kampmann, G. Obe, and T. Moroy Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and CDK4 Oncogene 15 1997 2615 2623
14. Y.A. Suh, R.S. Arnold, B. Lassegue, J. Shi, X. Xu, D. Sorescu, A.B. Chung, K.K. Griendling, and J.D. Lambeth Cell transformation by the superoxide-generating oxidase Mox1 Nature 401 1999 79 82
15. R.S. Arnold, J. Shi, E. Murad, A.M. Whalen, C.Q. Sun, R. Polavarapu, S. Parthasarathy, J.A. Petros, and J.D. Lambeth Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1 Proc. Natl. Acad. Sci. U.S.A. 98 2001 5550 5555
16. E. Pennisi Superoxides relay Ras protein's oncogenic message Science 275 1997 1567 1568
17. J. Mitsushita, J.D. Lambeth, and T. Kamata The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation Cancer Res. 64 2004 3580 3585
18. D.F. Calvisi, S. Ladu, K. Hironaka, V.M. Factor, and S.S. Thorgeirsson Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer J. Hepatol. 41 2004 815 822
19. E.A. Lutsenko, J.M. Carcamo, and D.W. Golde Vitamin C prevents DNA mutation induced by oxidative stress J. Biol. Chem. 277 2002 16895 16899
20. K.W. Lee, H.J. Lee, Y.J. Surh, and C.Y. Lee Vitamin C and cancer chemoprevention: reappraisal Am. J. Clin. Nutr. 78 2003 1074 1078
21. J.C. Vera, C.I. Rivas, J. Fischbarg, and D.W. Golde Mammalian facilitative hexose transporters mediate the transport of dehydroascorbic acid Nature 364 1993 79 82
22. H. Tsukaguchi, T. Tokui, B. Mackenzie, U.V. Berger, X.Z. Chen, Y. Wang, R.F. Brubaker, and M.A. Hediger A family of mammalian Na+-dependent l-ascorbic acid transporters Nature 399 1999 70 75
23. R. Daruwala, J. Song, W.S. Koh, S.C. Rumsey, and M. Levine Cloning and functional characterization of the human sodium-dependent Vitamin C transporters hSVCT1 and hSVCT2 FEBS Lett. 460 1999 480 484
24. J.C. Vera, C.I. Rivas, R.H. Zhang, C.M. Farber, and D.W. Golde Human HL-60 myeloid leukemia cells transport dehydroascorbic acid via the glucose transporters and accumulate reduced ascorbic acid Blood 84 1994 1628 1634
25. M. Levine, C. Conry-Cantilena, Y. Wang, R.W. Welch, P.W. Washko, K.R. Dhariwal, J.B. Park, A. Lazarev, J.F. Graumlich, J. King, and L.R. Cantilena Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance Proc. Natl. Acad. Sci. U.S.A. 93 1996 3704 3709
26. R.A. Smith, C.M. Porteous, C.V. Coulter, and M.P. Murphy Selective targeting of an antioxidant to mitochondria Eur. J. Biochem. 263 1999 709 716
27. I. Perez-Cruz, J.M. Carcamo, and D.W. Golde Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells Blood 102 2003 336 343
28. G.F. Kelso, C.M. Porteous, G. Hughes, E.C. Ledgerwood, A.M. Gane, R.A. Smith, and M.P. Murphy Prevention of mitochondrial oxidative damage using targeted antioxidants Ann. N.Y. Acad. Sci. 959 2002 263 274
29. J.M. Carcamo, A. Pedraza, O. Borquez-Ojeda, and D.W. Golde Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation Biochemistry 41 2002 12995 13002
30. M. Eilers, D. Picard, K.R. Yamamoto, and J.M. Bishop Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells Nature 340 1989 66 68
31. H. Wiseman, M.J. Laughton, H.R. Arnstein, M. Cannon, and B. Halliwell The antioxidant action of tamoxifen and its metabolites. Inhibition of lipid peroxidation FEBS Lett. 263 1990 192 194
32. R.C. Osthus, H. Shim, S. Kim, Q. Li, R. Reddy, M. Mukherjee, Y. Xu, D. Wonsey, L.A. Lee, and C.V. Dang Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc J. Biol. Chem. 275 2000 21797 21800
33. V.M. Factor, A. Kiss, J.T. Woitach, P.J. Wirth, and S.S. Thorgeirsson Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis J. Biol. Chem. 273 1998 15846 15853
34. D.J. Liao, and R.B. Dickson Cell death in MMTV-c-myc transgenic mouse mammary tumors may not be typical apoptosis Lab. Invest. 83 2003 1437 1449
35. J.A. Ellis, S.J. Mayer, and O.T. Jones The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbicidal activities of human neutrophils Biochem. J. 251 1988 887 891
36. H. Shim, C. Dolde, B.C. Lewis, C.S. Wu, G. Dang, R.A. Jungmann, R. Dalla-Favera, and C.V. Dang c-Myc transactivation of LDH-A: implications for tumor metabolism and growth Proc. Natl. Acad. Sci. U.S.A. 94 1997 6658 6663
37. G. Packham, and J.L. Cleveland Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis Mol. Cell. Biol. 14 1994 5741 5747
38. M. Auvinen, K. Jarvinen, A. Hotti, J. Okkeri, J. Laitinen, O.A. Janne, P. Coffino, M. Bergman, L.C. Andersson, K. Alitalo, and E. Holtta Transcriptional regulation of the ornithine decarboxylase gene by c-Myc/Max/Mad network and retinoblastoma protein interacting with c-Myc Int. J. Biochem. Cell. Biol. 35 2003 496 521
39. M.L. Wood, M. Dizdaroglu, E. Gajewski, and J.M. Essigmann Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome Biochemistry 29 1990 7024 7032
40. K. Arai, K. Morishita, K. Shinmura, T. Kohno, S.R. Kim, T. Nohmi, M. Taniwaki, S. Ohwada, and J. Yokota Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage Oncogene 14 1997 2857 2861
41. H. Aburatani, Y. Hippo, T. Ishida, R. Takashima, C. Matsuba, T. Kodama, M. Takao, A. Yasui, K. Yamamoto, and M. Asano Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue Cancer Res. 57 1997 2151 2156
42. K. Sakumi, M. Furuichi, T. Tsuzuki, T. Kakuma, S. Kawabata, H. Maki, and M. Sekiguchi Cloning and expression of cDNA for a human enzyme that hydrolyzes 8-oxo-dGTP, a mutagenic substrate for DNA synthesis J. Biol. Chem. 268 1993 23524 23530
43. K. Okamoto, S. Toyokuni, W.J. Kim, O. Ogawa, Y. Kakehi, S. Arao, H. Hiai, and O. Yoshida Overexpression of human mutT homologue gene messenger RNA in renal-cell carcinoma: evidence of persistent oxidative stress in cancer Int. J. Cancer 65 1996 437 441
44. D. Barsyte-Lovejoy, D.Y. Mao, and L.Z. Penn c-Myc represses the proximal promoters of GADD45a and GADD153 by a post-RNA polymerase II recruitment mechanism Oncogene 23 2004 3481 3486
45. S.A. Amundson, Q. Zhan, L.Z. Penn, and A.J. Fornace Jr. Myc suppresses induction of the growth arrest genes gadd34, gadd45, and gadd153 by DNA-damaging agents Oncogene 17 1998 2149 2154
46. A.L. Gartel, and K. Shchors Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes Exp. Cell. Res. 283 2003 17 21
47. K. Hironaka, V.M. Factor, D.F. Calvisi, E.A. Conner, and S.S. Thorgeirsson Dysregulation of DNA repair pathways in a transforming growth factor alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis Lab. Invest. 83 2003 643 654
48. R.W. Pak, V.J. Lanteri, J.R. Scheuch, and I.S. Sawczuk Review of Vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and Vitamin E chemoprevention trial Integr. Cancer Ther. 1 2002 338 344
49. A.A. Frimmer, and P. Gilinsky-Sharon Reaction of superoxide with ascorbic acid derivatives: insight into superoxide-mediated oxidation of dehydroascorbic acid J. Org. Chem. 60 1995 2796 2801
50. G.R. Buettner, and B.A. Jurkiewicz Chemistry and Biochemistry of Ascorbic Acid 1996 Marcel Dekker New York
51. X. Li, C.E. Cobb, K.E. Hill, R.F. Burk, and J.M. May Mitochondrial uptake and recycling of ascorbic acid Arch. Biochem. Biophys. 387 2001 143 153
52. X. Li, C.E. Cobb, and J.M. May Mitochondrial recycling of ascorbic acid from dehydroascorbic acid: dependence on the electron transport chain Arch. Biochem. Biophys. 403 2002 103 110
53. V.M. Factor, D. Laskowska, M.R. Jensen, J.T. Woitach, N.C. Popescu, and S.S. Thorgeirsson Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model Proc. Natl. Acad. Sci. U.S.A. 97 2000 2196 2201
54. T. Paraidathathu, J. Palamanda, and J.P. Kehrer Modulation of rat heart mitochondrial function and the production of reactive oxygen by Vitamin E deficiency Toxicology 90 1994 103 114
55. O. Cachia, J.E. Benna, E. Pedruzzi, B. Descomps, M.A. Gougerot-Pocidalo, and C.L. Leger Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation J. Biol. Chem. 273 1998 32801 32805
56. B. Chance, H. Sies, and A. Boveris Hydroperoxide metabolism in mammalian organs Physiol. Rev. 59 1979 527 605
57. J.G. Zhang, F.A. Nicholls-Grzemski, M.A. Tirmenstein, and M.W. Fariss Vitamin E succinate protects hepatocytes against the toxic effect of reactive oxygen species generated at mitochondrial complexes I and III by alkylating agents Chem. Biol. Interact 138 2001 267 284
58. A.G. Bowie, and L.A. O'Neill Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase J. Immunol. 165 2000 7180 7188
59. J.M. Carcamo, A. Pedraza, O. Borquez-Ojeda, B. Zhang, R. Sanchez, and D.W. Golde Vitamin C is a kinase inhibitor: dehydroascorbic acid inhibits IkappaBalpha kinase beta Mol. Cell. Biol. 24 2004 6645 6652
60. F.A. La Rosa, J.W. Pierce, and G.E. Sonenshein Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors Mol. Cell. Biol. 14 1994 1039 1044
61. D.W. Kim, M.A. Sovak, G. Zanieski, G. Nonet, R. Romieu-Mourez, A.W. Lau, L.J. Hafer, P. Yaswen, M. Stampfer, A.E. Rogers, J. Russo, and G.E. Sonenshein Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells Carcinogenesis 21 2000 871 879